Trials / Completed
CompletedNCT00646126
Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission
Validation of the Use of Istope-Based Molecular Techniques for Malaria Control
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Tropical Medicine Research Institute · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Accepted
Summary
The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry season in areas of seasonal malaria transmission. Targeting this parasite reservoir before the transmission season could be a good strategy for malaria control. We are conducting a randomized double blind placebo controlled mass drug administration trial in eight village to clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in eastern Sudan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS) | Standard three day regimen |
| DRUG | placebo tablet similar to active drug in shape and size | Dosage similar to active drug(standard three days regimen) |
Timeline
- Start date
- 2005-08-01
- First posted
- 2008-03-28
- Last updated
- 2008-03-28
Locations
1 site across 1 country: Sudan
Source: ClinicalTrials.gov record NCT00646126. Inclusion in this directory is not an endorsement.